{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:04:14Z","timestamp":1790888654720,"version":"4.1.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Invasive Fusarium infections cause high mortality. Fosmanogepix, a first-in-class antifungal agent, has potent activity against Fusarium. A patient with acute leukemia with invasive fusariosis, probably involving the central nervous system and caused by Fusarium lactis resistant to currently available antifungal agents, was cured of her infection with fosmanogepix. Fosmanogepix was well tolerated.<\/jats:p>","DOI":"10.1093\/cid\/ciad309","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:37:05Z","timestamp":1684867025000},"page":"848-850","source":"Crossref","is-referenced-by-count":28,"title":["Fosmanogepix Therapy of Disseminated\n                    <i>Fusarium<\/i>\n                    Infection"],"prefix":"10.1093","volume":"77","author":[{"given":"Drew J","family":"Winston","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California , Los Angeles , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A","family":"Young","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California , Los Angeles , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haran T","family":"Schlamm","sequence":"additional","affiliation":[{"name":"HTS Pharma Consulting , San Diego, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J","family":"Schiller","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California , Los Angeles , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"2023100601381360800_ciad309-B1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2023100601381360800_ciad309-B2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/myc.12271","article-title":"Fusarium brain abscess: case report and literature review","volume":"58","author":"Ramos","year":"2015","journal-title":"Mycoses"},{"key":"2023100601381360800_ciad309-B3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/jeccm-21-125","article-title":"Fast and fusariosis: a systematic review and case report of a rapidly fatal central nervous system infection","volume":"6","author":"Vadhan","year":"2022","journal-title":"J Emerg Crit Care Med"},{"key":"2023100601381360800_ciad309-B4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/jof6040239","article-title":"Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"Shaw","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2023100601381360800_ciad309-B5","article-title":"Fosmanogepix (APX001) is effective in the treatment of immunocompromised mice infected with invasive pulmonary scedosporiosis or disseminated fusariosis","volume":"64","author":"Alkhazraiji","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2023100601381360800_ciad309-B6","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1093\/ofid\/ofaa439.457","article-title":"Clinical safety and efficacy of novel antifungal, fosmanogepix, in the treatment of candidemia: results from a phase 2 proof of concept trial","volume":"7","author":"Pappas","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2023100601381360800_ciad309-B7","volume-title":"Performance standards for antifungal susceptibility testing of filamentous fungi","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2022","edition":"3rd ed"},{"key":"2023100601381360800_ciad309-B8","first-page":"1371","article-title":"Fusarium's molecular diversity and intrinsic drug resistance","volume":"10","author":"Al-Halami","year":"2016","journal-title":"PLoS Pathogens"},{"key":"2023100601381360800_ciad309-B9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1469-0691.12409","article-title":"Improvement in the outcome of invasive fusariosis in the last decade","volume":"20","author":"Nucci","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2023100601381360800_ciad309-B10","doi-asserted-by":"crossref","first-page":"S526","DOI":"10.1093\/ofid\/ofx163.1370","article-title":"First-in-humans study to assess safety, tolerability and pharmacokinetics of APX001 administered by intravenous infusion to healthy subjects","volume":"4","author":"Hodges","year":"2017","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad309\/50607855\/ciad309.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/6\/848\/51906112\/ciad309.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/6\/848\/51906112\/ciad309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T21:39:56Z","timestamp":1696541996000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/77\/6\/848\/7176283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":10,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,5,23]]},"published-print":{"date-parts":[[2023,9,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad309","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,15]]},"published":{"date-parts":[[2023,5,23]]}}}